They are among 30 recipients of the fellowships, which honor immigrants and children of immigrants with exceptional potential to make a difference in their fields
Gain Therapeutics Announces 2024 R&D Update on Parkinson s Disease with KOL & Analyst Insight streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Event, moderated by Hartaj Singh and Eka Gigauri of Oppenheimer & Co., will be held on Thursday, February 22, 2024 at 11:00 am ESTBETHESDA, Md., Feb. 14, 2024 Gain Therapeutics, Inc., , a.
14.02.2024 - Event, moderated by Hartaj Singh and Eka Gigauri of Oppenheimer & Co., will be held on Thursday, February 22, 2024 at 11:00 am ESTBETHESDA, Md., Feb. 14, 2024 (GLOBE NEWSWIRE) - Gain Therapeutics, Inc., (Nasdaq: GANX), a clinical-stage . Seite 1
A growing body of research suggests that genes may be our best shot at advancing the treatment and management of Parkinson s disease, prompting experts to call for broad-based genetic testing.